Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy

Myasthenia gravis (MG) is an immune-related adverse event (irAE), and as an irAE, MG (irAE-MG) generally has a monophasic course, with only a few case reports of irAE-MG flare-ups during the course of the disease. We herein report a case of pembrolizumab-induced MG with relapsing symptoms. irAE-MG i...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Yuki, Fujii, Shintaro, Horiuchi, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683818/
https://www.ncbi.nlm.nih.gov/pubmed/35400705
http://dx.doi.org/10.2169/internalmedicine.8554-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683818/
https://www.ncbi.nlm.nih.gov/pubmed/35400705
http://dx.doi.org/10.2169/internalmedicine.8554-21

Ejemplares similares